Search
for
Sort by
Research 961–990 of 1000+
- The Social Capital of Social Media: A Correlational Study of Facebook Use, Campus Attachment, and Involvement
- New Drugs: Dutasteride
- Editorial Comments
- Finasteride treatment and neuroactive steroid formation.
- Effects of Finasteride on Vascular Endothelial Growth Factor
- Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men
- An overview on 5α-reductase inhibitors
- Editorial Comment
- Major role for 5-alpha reductase inhibitors in the aging male
- AB089. What should we know role of finasteride in erectile dysfunction?
- Tratamiento de la Depresión durante el embarazo: perspectivas clínicas
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- Microencapsulation of Poorly Water-soluble Finasteride in Polyvinyl Alcohol/chitosan Microspheres as a Long-term Sustained Release System for Potential Embolization Applications
- How Many Drugs for LUTS Due to BPH are Too Many?
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- Proscar and Propecia: the Gary and Jerry show
- Saw Palmetto (Serenoa repens)
- Efficacy of Combination of Tamsulosin and Finasteride on Urinary Symptoms and IPSS Score for Elderly Patients with BPH
- How Much Worse Will My Voiding Symptoms Get over Time?
- New Drugs: Eculizumab
- Editorial Comment
- Finasteride and dutasteride may reduce melanoma risk
- 5α‐Reductase Inhibitors
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Saw Palmetto (Serenoa repens)
- This Month in Adult Urology